<!DOCTYPE HTML>
<html>
  <head>
    <meta http-equiv="Content-type" content="text/html;" >
	<title>Topiramate</title>
	</head>
  <body onLoad="init();">
    <div data-role="page" data-theme="b">
  	<div data-role="header" data-theme="b" data-position="fixed">
    	<h1>Topiramate</h1> 
    	<a href="#" data-rel="back" data-icon="arrow-l" data-theme="b" data-direction="reverse" >Back</a>
	</div>
    <div data-role="content">
<h3>Brand name: Topamax</h3>

<hr>
					<h3>Adult Starting Dose (Max Per Day)</h3>	
					<ul>
						<li>Initial dose = 25- 50mg/day given in 2 divided doses and increase by 15-50mg/ week to the maximum dose or as tolerated</li>
						<li>Target dose = 200-400mg/ day </li>
						<li>Max dose = 400mg/day </li>
						<li>Headache dose = 25-100mg twice daily </li>
					</ul>
<hr>
					<h3>Advantages</h3>	
					<ul>
						<li>May cause weight loss in some patients </li> 
						<li>May use in mTBI patients for headache</li> 
					</ul>
<hr>
					<h3>Disadvantages</h3>	
					<ul>
						<li>Contraindications include hepatic impairment </li>
						<li>Adverse Events: Angle closure glaucoma, anorexia, sedation, dizziness and ataxia</li>
						 <li>Adjust the dose in renal impairment </li>
						 <li>Do not use in patients with h/o kidney stones or glaucoma </li>
						 <li>Common issues in mTBI: may worsen cognitive dysfunction, may cause renal stones </li>
						 <li>Instruct patient to maintain adequate hydration to prevent kidney stone formation</li>
					</ul>
<hr>
					<h3>Pregnancy Category</h3>	
					<ul>
							<li>Risk cannot be ruled out, but potential benefits may justify potential risk</li>	
					</ul>
<hr>
					<h3>Safety Margin</h3>	
					<ul>
						<li>Can experience serious toxicity, narrow window of safety </li>
						<li>Carbamazepine use contraindicated with nefazodone or within 14 days of MAOI use</li> 
						<li>Avoid concurrent use with alcohol and CNS depressants </li>
						<li>Avoid concomitant use of Carbamazepine with darunavir, etravirine, nilotinib, ranolazine and voriconazole; Avoid concurrent use with grapefruit juice</li> 
						<li>Avoid concurent use of oxcarbazepine with nilotinib, nisoldipine, ranolazine </li>
						<li>Avoid concurrent use with evening primrose, valerian, st. john's wort and kava kava</li>					
					</ul>
<hr>
					<h3>Efficacy</h3>	
					<ul>
						<li>Migraines: topiramate and Valproic Acid are FDA approved for prophylaxis use </li>
						<li>Bipolar disorder: lamotrigine is FDA approved for use; Valproic Acid (Stavzor) is FDA approved for use in mania in bipolar disorder; Carbamazepine (Equetro) is FDA approved for use in acute manic and mixed episodes associated with bipolar disorder</li> 
						<li>Trigeminal neuralgia: Carbamazepine (except Equetro) is FDA approved for use </li>
						<li>Alcohol withdrawal: Carbamazepine has fair documentation for use and oxcarbazepine has good documentation for use</li> 
						<li>Posthepetic neuralgia: gabapentin is FDA approved for use </li>
						<li>Neuralgia, chronic pain and neuropathy: gabapentin has fair documentation for use</li>
					</ul>



    </div><!-- end jqm content -->
   
    </div><!-- end jqm page -->
  </body>
</html>
